Anixa Biosciences (ANIX) said Monday that the Canadian Intellectual Property Office has issued a notice of allowance for a patent covering the company's ovarian cancer vaccine technology.
The patent, exclusively licensed from Cleveland Clinic, includes methods of administering an immunogenic composition comprising a nucleic acid encoding the anti-Mullerian hormone receptor 2 polypeptide, the company said.
Price: $2.72, Change: $+0.02, Percent Change: +0.74%
Oncolytics Biotech (ONCY) said Monday that initial results from a preclinical study assessing pelareorep plus RAS inhibitor modalities in a solid tumor model showed evidence of the combination's greater anti-tumor activity than with the individual approaches alone.The company said that, based on the results, it is planning further studies in models of pancreatic ductal adenocarcinoma and colorectal cancer to further assess the combinations' anti-tumor and immune effects.Full results from the initial preclinical studies are slated to be presented in the fall or winter of this year, Oncolytics said.The company's shares were up more than 8% in Monday premarket trading.
MGM Resorts International (MGM) has an average rating of overweight and mean price target of $45.26, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $48.57, Change: $+4.90, Percent Change: +11.22%
VeriSign (VRSN) has an average rating of hold and mean price target of $308.25, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $288.87, Change: $+3.49, Percent Change: +1.22%